Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas. - Wikidata - awgldk - TriplyDB

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

http://www.wikidata.org/entity/Q33809397

about

RTEL1 tagging SNPs and haplotypes were associated with glioma development A prognostic analysis of pediatrics central nervous system small cell tumors: evaluation of EGFR family gene amplification and overexpression.Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma Rapid detection of high-level oncogene amplifications in ultrasonic surgical aspirations of brain tumors.Correlation of microRNA-372 upregulation with poor prognosis in human glioma.Expression and clinical significance of the proliferation marker minichromosome maintenance protein 2 (Mcm2) in diffuse astrocytomas WHO grade II Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors.Human epidermal growth factor receptor 2/neu protein expression in meningiomas: An immunohistochemical study.Expression and clinical value of EGFR in human meningiomas.C-erbB2/HER2 in human gliomas, medulloblastomas, and meningiomas: a minireview.miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: meta-analysis.Silencing of Her2, CCNB1 and PKC Genes by siRNA Results in Prolonged Retardation of Neuroblastoma Cell Division Efficacy of HER2 retargeted herpes simplex virus as therapy for high-grade glioma in immunocompetent mice.Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9.Prognostic value of ErbB2/HER2 in human meningiomas

P2860

Q28383341-7924F925-B46A-44FF-AFC1-79DDF138408B Q34486255-769D7EAA-6ADF-45AF-9F0B-B27C5C128719 Q35081279-B7E66A97-4383-41E3-8E3A-89EAC5B42304 Q35939421-15000DDE-506C-4FE9-BC0B-81EA437B0FE9 Q36329368-A14D0277-15D5-42A2-B133-78274A403292 Q36552246-2B42ECB9-5B8D-4D98-B127-72F70D132659 Q36827857-D8E51949-7CB2-4F67-BF97-7765EA936E00 Q37153458-2978B129-6CBB-46A2-AD03-73A91AB0B104 Q37221158-7E8DB987-0D0E-42E2-B681-2E21A4040C52 Q37732068-62F5ACC1-F2DB-43D1-8319-D926C5C528DA Q38120594-F8100823-2065-4DE3-B880-8E8896D87181 Q38849525-E3B3EC54-A2E9-45C2-ADD1-E2D3315DD20B Q41110170-E3812950-C526-4DBE-8FE8-4DDF3A772675 Q42153175-B8B7E77F-1ED9-4B02-8C83-F1EE9EBF0C12 Q45354666-F7E18295-0DE0-474A-880D-7B51D6E77CFA Q47654279-0046C588-027B-4F55-883F-CE72E8549065 Q58601833-7F785139-D2D1-487D-AF0B-8809C1AD4D9B

P2860

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

http://www.wikidata.org/entity/Q33809397

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

@ast

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

@en

type

label

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

@ast

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

@en

prefLabel

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

@ast

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

@en

P1433

Q33809397-AB1C5254-ACBA-48F8-BD88-1151A2F4CC9E

P1476

Q33809397-46D915DB-6DDD-40A0-9DE8-43C908FD2211

P2093

Q33809397-798EB949-663F-41F5-B199-C9221E88349F

Q33809397-7AF91879-AEE3-4DC3-8212-9984789C22B6

Q33809397-C18A52A0-FCD3-41DC-A6FB-3EBD47477F28

Q33809397-F1FE3217-B82B-4A6C-A983-12A6DE03C804

Q33809397-F6125A85-7198-4F72-934F-ACFA62B25405

Q33809397-F65633F5-9A79-4EA6-9B74-9DC4DF3068A9

P2860

Q33809397-09921DA5-7FA4-4388-90A8-62478880F535

Q33809397-0AAF6758-B8B3-4F1F-AC49-FCF1331F57D6

Q33809397-185C62B8-532A-4A60-AF2B-9D786E2C338E

Q33809397-24CC2F6B-0663-46C0-ACA6-87ECD5F5F63C

Q33809397-2993F73C-9E12-4876-A23D-46BB31DA2281

Q33809397-30D445A9-84CD-41B7-9DE8-6802D76B14EB

Q33809397-313E0ABE-E846-4D1B-B96F-A8103DD9A6AD

Q33809397-31DA7A76-BB4B-4BF6-AAEB-BBC39956BFB0

Q33809397-3591E2C2-E027-4495-B305-9B07537C83C7

Q33809397-3A58A7E6-E3E3-4DC1-8716-BDE15BD5E89A

P2888

Q33809397-3A73B108-07F1-4CF4-9164-1D48EC3767C3

P304

Q33809397-AC1FC125-BA71-4F99-B763-AE44EEE1981B

P31

Q33809397-6F97D7BF-907E-48ED-A987-AAB7FAD802FD

P356

Q33809397-D6E95F4E-97E2-4B7A-987E-399CECA94FE8

P478

Q33809397-074B680C-A235-442D-924D-AAA8917CDD6F

P577

Q33809397-A699FA4D-FAC2-428E-B82E-20531CFBB7DB

P5875

Q33809397-FD83F8A6-8FE1-49C3-882C-97A628C997F8

P6179

Q33809397-709447F6-E48E-4838-ACA3-87F9878EEF00

P698

Q33809397-2AA4B9B3-B007-4374-833F-5F3C3E84CF1D

P921

Q33809397-0BBBB8D2-0AFC-4024-B3C5-7C94FDF4713B

P932

Q33809397-FE42EB1A-03A5-491A-9A21-FF1ECEEE83DB

P356

P1433

Diagnostic Pathology

P1476

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

@en

P2093

Borgny Ytterhus

http://www.w3.org/2001/XMLSchema#string

Michel Gulati

http://www.w3.org/2001/XMLSchema#string

Sasha Gulati

http://www.w3.org/2001/XMLSchema#string

Stian Lydersen

http://www.w3.org/2001/XMLSchema#string

Sverre H Torp

http://www.w3.org/2001/XMLSchema#string

Unn S Granli

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

Cell signaling by receptor tyrosine kinases

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

EGFRvIII-targeted vaccination therapy of malignant glioma.

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.

Growth factors in gliomas revisited.

EGF mutant receptor vIII as a molecular target in cancer therapy.

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

P2888

P304

18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1746-1596-5-18

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42440296

http://www.w3.org/2001/XMLSchema#string

P6179

1024029368

http://www.w3.org/2001/XMLSchema#string

P698

20331873

http://www.w3.org/2001/XMLSchema#string

P921

P932

2859381

http://www.w3.org/2001/XMLSchema#string